Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;56(11):5804-10.
doi: 10.1128/AAC.01296-12. Epub 2012 Aug 27.

Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms

Affiliations

Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms

Jongkon Saising et al. Antimicrob Agents Chemother. 2012 Nov.

Abstract

Due to their abilities to form strong biofilms, Staphylococcus aureus and Staphylococcus epidermidis are the most frequently isolated pathogens in persistent and chronic implant-associated infections. As biofilm-embedded bacteria are more resistant to antibiotics and the immune system, they are extremely difficult to treat. Therefore, biofilm-active antibiotics are a major challenge. Here we investigated the effect of the lantibiotic gallidermin on two representative biofilm-forming staphylococcal species. Gallidermin inhibits not only the growth of staphylococci in a dose-dependent manner but also efficiently prevents biofilm formation by both species. The effect on biofilm might be due to repression of biofilm-related targets, such as ica (intercellular adhesin) and atl (major autolysin). However, gallidermin's killing activity on 24-h and 5-day-old biofilms was significantly decreased. A subpopulation of 0.1 to 1.0% of cells survived, comprising "persister" cells of an unknown genetic and physiological state. Like many other antibiotics, gallidermin showed only limited activity on cells within mature biofilms.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Growth curves of S. aureus SA113 and S. epidermidis O47 after treatment with gallidermin at 1×, 2×, 4×, and 8× MIC of gallidermin. Gallidermin was added at the mid-exponential growth phase, after 4 h of cultivation. The MIC values of gallidermin for S. aureus SA113 and S. epidermidis O47 were 8 and 4 μg/ml, respectively.
Fig 2
Fig 2
Biofilm formation of S. aureus SA113 and S. epidermidis O47 in the presence of subinhibitory concentrations of gallidermin. Growth and biofilm formation occurred in microtiter plates. Shown are the turbidity (the OD600) of the cell culture (A), the absorbance (A570) of stained cells attached to the surface after washing (B), and photos of biofilm cells attached to microtiter wells after crystal violet staining (C). Differences were considered significant at P < 0.05.
Fig 3
Fig 3
Gallidermin and viability of bacterial cells in 24-h and 5-day established biofilms of S. aureus SA113 and S. epidermidis O47. The viability of bacterial cells in 24-h and 5-day biofilms was detected by MTT assay (A) or viable count (B). Differences were considered significant at P < 0.05.
Fig 4
Fig 4
Effects of gallidermin on atl and ica transcription. RNA from S. aureus SA113 and S. epidermidis O47 was taken from 4-, 6-, and 8-h cultures (with or without 4× MIC gallidermin treatment) and analyzed by Nothern blotting. 23S rRNA was used as a control.
Fig 5
Fig 5
Autolysin zymogram profiles. S. aureus SA113 and S. epidermidis O47 were treated with or without 4× MIC of gallidermin, and the cell wall-associated proteins were separated by SDS-PAGE with heat-inactivated Micrococcus luteus cells as the substrate. Proteins with autolysin activity were visualized as clear (white) bands.

Similar articles

Cited by

References

    1. Augustin J, et al. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1149–1154 - PubMed
    1. Bera A, et al. 2007. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 189:280–283 - PMC - PubMed
    1. Bierbaum G, Brötz H, Koller KP, Sahl HG. 1995. Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol. Lett. 127:121–126 - PubMed
    1. Bonelli RR, Schneider T, Sahl HG, Wiedemann I. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 50:1449–1457 - PMC - PubMed
    1. Brötz H, et al. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317–327 - PubMed

Publication types

MeSH terms